Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Clinical trial NCT01868451 · COMPLETED
Trial details
- NCT number
- NCT01868451
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2026-06-02
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.